U.S. Value Funds Beat Growth in the First Quarter
The difference between growth and value funds was stark.
Stay updated with breaking news from Kodiak Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The difference between growth and value funds was stark.
/PRNewswire/ -- DelveInsight's Vitreoretinal Surgery Devices Market Insights and Forecast report provides the current and forecast Vitreoretinal Surgery...
Today's losers are selling for peanuts, and they just might become tomorrow's winners.
Kodiak Sciences (NASDAQ:KOD – Get Rating) had its price target trimmed by Roth Capital from $149.00 to $75.00 in a research note published on Monday, The Fly reports. KOD has been the subject of several other research reports. Barclays cut their price target on Kodiak Sciences from $81.00 to $50.00 and set an underweight rating […]
Key appointment as Opthea progresses the Phase 3 clinical development of OPT-302 in wet AMD